Nirsevimab 50MG PFS 5S
Ended Awarded
- Contract number
- SPE2DX26FPFUU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,339
Award facts
- Contract value 100% obligated
- $5,339.46 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a $5,339.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Nirsevimab 50mg prefilled syringes (5-pack). This delivery order, issued on October 22, 2025, carries an ultimate completion date of October 22, 2025, and was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. Nirsevimab is a monoclonal antibody indicated for respiratory syncytial virus prevention in infants and young children, representing a specialized pharmaceutical product within the Defense Logistics Agency's broader medical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical prime vendor serving Department of Defense military healthcare facilities worldwide. The company's established track record delivering diverse pharmaceutical products—ranging from oncology treatments to biologics, vaccines, and specialty surgical products—demonstrates its capability to fulfill the specialized medical supply requirements essential to global military healthcare operations.
Quick answers
Who was awarded contract SPE2DX26FPFUU?
SPE2DX26FPFUU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 22, 2025.
How much is contract SPE2DX26FPFUU worth?
The government has obligated $5,339 on SPE2DX26FPFUU.
Is contract SPE2DX26FPFUU an order under another contract?
Yes. SPE2DX26FPFUU is a delivery order under SPE2DX15D9762, an indefinite delivery contract.
Was contract SPE2DX26FPFUU competed?
The extent of competition for SPE2DX26FPFUU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award